Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Tongxin Dropping Pill for stable angina pectoris
ChiCTR2300073603Phase 4Recruiting
- Sponsor
- Shuguang Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Shexiang Tongxin Dropping Pills in coronary arteriosclerosis and stable angina (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Seattle Angina Questionnaire score. Started Jun 2023; status: recruiting.
02
Drugs
Shexiang Tongxin Dropping Pills
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2300073603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073603.